Cargando…

Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a disease characterised by new bone formation. Biologic agents targeting TNFα or IL-17 are used widely and are very effective in controlling symptoms and improving quality of life in these patients. However, the effect of biologics on radiographic progression is st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klavdianou, Kalliopi, Kanellou, Anastasia, Daoussis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:	Narrative Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450187/ https://www.ncbi.nlm.nih.gov/pubmed/36127924 http://dx.doi.org/10.31138/mjr.33.1.115

Ejemplares similares

JAK Inhibitors for the Treatment of Axial Spondyloarthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2023)

Dkk1: A key molecule in joint remodelling and fibrosis
por: Klavdianou, Kalliopi, et al.
Publicado: (2017)

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Klavdianou, Kalliopi, et al.
Publicado: (2021)

MRI of the axial skeleton in spondyloarthritis: the many faces of new bone formation
por: Laloo, Frederiek, et al.
Publicado: (2019)

Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2020)

Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis
por: Lories, Rik JU, et al.
Publicado: (2009)

DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17
por: Daoussis, Dimitrios, et al.
Publicado: (2022)

Low bone mineral density predicts the formation of new syndesmophytes in patients with axial spondyloarthritis
por: Kim, Hyoung Rae, et al.
Publicado: (2018)

New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT
por: Diekhoff, Torsten, et al.
Publicado: (2023)

Patient Burden of Axial Spondyloarthritis
por: Strand, Vibeke, et al.
Publicado: (2017)

Uncovering the Underworld of Axial Spondyloarthritis
por: Del Vescovo, Sergio, et al.
Publicado: (2023)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

The prevalence of fibromyalgia in axial spondyloarthritis
por: Jones, Gareth T., et al.
Publicado: (2020)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022)

Targeting inflammatory pathways in axial spondyloarthritis
por: Furst, Daniel E., et al.
Publicado: (2019)

Recent advances in managing axial spondyloarthritis
por: Agrawal, Priyanka, et al.
Publicado: (2020)

Clinical Manifestations and Diagnosis of Axial Spondyloarthritis
por: Walsh, Jessica A., et al.
Publicado: (2021)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Searching for New Genetic Biomarkers of Axial Spondyloarthritis
por: Bugaj, Bartosz, et al.
Publicado: (2022)

Old and new treatment targets in axial spondyloarthritis
por: Rios Rodriguez, Valeria, et al.
Publicado: (2015)

Exploration of the Utility of Speckle-Tracking Echocardiography During Mechanical Ventilation and Mechanical Circulatory Support
por: Sato, Kei, et al.
Publicado: (2022)

Transfusion in the mechanically ventilated patient
por: Juffermans, Nicole P., et al.
Publicado: (2020)

New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review
por: Perrotta, Fabio Massimo, et al.
Publicado: (2019)

Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis
por: Paroli, Marino, et al.
Publicado: (2023)

Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance
por: Ghosh, Nilasha, et al.
Publicado: (2017)

Defining the target: clinical aims in axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2018)

Comorbid pain in axial spondyloarthritis, including fibromyalgia
por: López-Medina, Clementina, et al.
Publicado: (2020)

The role of ixekizumab in non-radiographic axial spondyloarthritis
por: San Koo, Bon, et al.
Publicado: (2021)

New Biomarkers for Cardiovascular Disease
por: Kim, Stephanie J., et al.
Publicado: (2023)

Severe acute respiratory syndrome and thyroid: A molecular point of view
por: Sadoughi, Fatemeh, et al.
Publicado: (2022)

Cortical bone loss is an early feature of nonradiographic axial spondyloarthritis
por: Neumann, Anna, et al.
Publicado: (2018)

Molecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review
por: Sharif, Nadim, et al.
Publicado: (2023)

Cytokine profiles in axial spondyloarthritis
por: Madej, Marta, et al.
Publicado: (2015)

Axial Spondyloarthritis and Cigarette Smoking
por: Kaut, Irène Kona, et al.
Publicado: (2017)

Axial spondyloarthritis: coming of age
por: Marzo-Ortega, Helena
Publicado: (2020)

Genetics and the axial spondyloarthritis spectrum
por: Brown, Matthew A, et al.
Publicado: (2020)

Work Disability in Axial Spondyloarthritis
por: Nikiphorou, Elena, et al.
Publicado: (2020)

Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies
por: Madanchi, Nima, et al.
Publicado: (2017)

Historical development of the anesthetic machine: from Morton to the integration of the mechanical ventilator
por: Romero-Ávila, Pablo, et al.
Publicado: (2021)

An End-User’s Personal Perspective on the Need of Consumer Involvement in Research
por: Ferry, S. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oi3om53hjc76i4ash57l2j4g0m